AG
OCRX

Advisor Group’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Advisor Group’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,200
Closed -$1K – 5195
2017
Q3 		$1K Buy
1,200
+200
+20% +$214 ﹤0.01% 4795
2017
Q2 		$1K Hold
1,000
– – ﹤0.01% 4750
2017
Q1 		$1K Buy
+1,000
New +$1.27K ﹤0.01% 4641

Advisor Group's OCRX Position: Q4 2017 in Review

Advisor Group sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 1,200 shares — an estimated $1K sold.

Advisor Group first reported a position in OCRX in Q1 2017 and held it in 3 quarters. The position peaked at $1K in Q3 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

  • Advisor Group reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Advisor Group sold 1,200 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $1K.
  • Advisor Group first reported a position in Ocera Therapeutics, Inc. in Q1 2017 and held it in 3 quarters.
  • Advisor Group's Ocera Therapeutics, Inc. position peaked at $1K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on Advisor Group's 13F filing for Q4 2017, filed 14 Feb 2018.